Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 1
2017 pubmed 39 citations

GDM alters paracrine regulation of feto-placental angiogenesis via the trophoblast.

Loegl. Jelena J; Nussbaumer. Erika E; Cvitic. Silvija S; Huppertz. Berthold B; Desoye. Gernot G; Hiden. Ursula U

Key Findings

  • Gestational diabetes alters the secreted factors from placental trophoblasts, boosting 2D network formation of fetal endothelial cells while reducing wound healing and chemotaxis.
  • Expression of angiogenesis-related genes ANGPT2, HGF, KISS1, and PLGF is significantly changed in GDM trophoblasts.
  • GDM trophoblasts secrete less pigment epithelium-derived factor (PEDF) and tumor necrosis factor-alpha (TNF-α).

Practical Outcomes

  • The study highlights how gestational diabetes can disrupt placental blood vessel formation via altered kisspeptin (KISS1) signaling, but it offers no direct actions for biohackers or longevity enthusiasts. It suggests that kisspeptin's role is context-specific to pregnancy and not readily translatable to adult health protocols.

Summary

In pregnancies with gestational diabetes, the cells that line the placenta (trophoblasts) release different amounts of signaling proteins, including the kisspeptin-related gene KISS1, which changes how nearby blood vessel cells grow and move. These changes could affect the placenta's blood vessel network but don't give clear guidance for everyday health or performance hacks.

Abstract

Feto-placental angiogenesis and vascular development are tightly regulated by pro- and anti-angiogenic factors. Villous trophoblast may be a major source of these factors. It forms the classical placental barrier between mother and fetus, and is thus exposed to maternal influences as well. Metabolic and hormonal derangements in gestational diabetes mellitus (GDM) affect feto-placental angiogenesis and vascular growth. Here we hypothesized that GDM alters the trophoblast secretome, which will modulate the paracrine regulation of feto-placental angiogenesis. Primary term trophoblasts were isolated from normal (n=6) and GDM (n=6) pregnancies. Trophoblast conditioned medium (CM) was used to investigate paracrine effects of normal and GDM-exposed trophoblasts on feto-placental endothelial cells (fpECs; n=7), using functional assays for 2D network formation, wound healing, chemotaxis, and proliferation. Gene expression of 23 pro- and anti-angiogenic factors was analyzed. Four trophoblast-derived paracrine regulators of angiogenesis were specifically measured in CM. CM from GDM trophoblasts increased 2D network formation of fpEC by 2.4-fold (P<0.001), whereas wound healing was attenuated by 1.8-fold (P=0.02) and chemo-attraction to the CM was reduced by 33±9% (P=0.02). The effect of CM on proliferation was unchanged between normal and GDM trophoblasts. Expression analysis of pro- and anti-angiogenic molecules in normal and GDM trophoblasts revealed significant differences in ANGPT2, HGF, KISS1 and PLGF expression. Analysis of secreted proteins demonstrated reduced pigment epithelium derived factor and tumor necrosis factor-α secretion by GDM trophoblasts. GDM alters the balance of trophoblast derived, angiogenesis modulating paracrine factors. This may contribute to GDM-associated changes in placental angiogenesis and vascular structure.

Study Information

Provider

pubmed

Year

2017

Date

2017-01-23T00:00:00.000Z

DOI

10.1038/labinvest.2016.149

Citations

39

References

42